Osteoporosis in Inflammatory Bowel Disease

Ali, Tauseef; Lam, David; Bronze, Michael S.; Humphrey, Mary Beth

doi:10.1016/j.amjmed.2009.01.022

« Previous Next »The American Journal of Medicine
Volume 122, Issue 7 , Pages 599-604, July 2009

Osteoporosis in Inflammatory Bowel Disease

Tauseef Ali, MD
- Department of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City
- Section of Digestive Diseases and Nutrition, University of Oklahoma Health Sciences Center, Oklahoma City
David Lam, MD
- Department of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City
Michael S. Bronze, MD
- Department of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City
Mary Beth Humphrey, MD, PhD
- Department of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City
- Section of Rheumatology, Immunology and Allergy, University of Oklahoma Health Sciences Center, Oklahoma City
- Requests for reprints should be addressed to Mary Beth Humphrey, MD, PhD, Department of Medicine, University of Oklahoma Health Sciences Center, 975 N.E. 10^th St., BRC 209, Oklahoma City, OK 73104

Abstract

Osteoporosis commonly afflicts patients with inflammatory bowel disease, and many factors link the 2 states together. A literature review was conducted about the pathophysiology of osteoporosis in relation to inflammatory bowel disease. Screening guidelines for osteoporosis in general as well as those directed at patients with inflammatory bowel disease are reviewed, as are currently available treatment options. The purpose of this article is to increase physician awareness about osteopenia and osteoporosis occurring in patients with inflammatory bowel disease and to provide basic, clinically relevant information about the pathophysiology and guidelines to help them treat these patients in a cost-effective manner.

Keywords: Inflammatory bowel disease, Osteopenia, Osteoporosis